Oxaliplatin Recruiting Phase 3 Trials for Esophageal Adenocarcinoma (UICC TNM7) / Adenocarcinomas of the Gastroesophageal Junction Treatment

IndicationsStatusPurposePhase
RecruitingTreatment3
clinicaltrials.gov IdentifierTitleDrugs
NCT02509286Perioperative Chemotherapy Compared To Neoadjuvant Chemoradiation in Patients With Adenocarcinoma of the Esophagus
NCT04375605Neoadjuvant RCT Versus CT for Patients With Locally Advanced, Potentially Resectable Adenocarcinoma of the GEJ
NCT03986385Apatinib Plus Concurrent Neoadjuvant Chemoradiotherapy for Gastroesophageal Junction